Burning Rock Biotech Limited Stock Analysis & AI Score
Burning Rock Biotech Limited (BNR) has an ST Score of 59.3 (B-), driven by its Valuation (A+) and held back by its Profitability (D). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Burning Rock Biotech Limited (BNR) has an ST Score of 59.3 (B-), driven by its Valuation (A+) and held back by its Profitability (D). Analysts rate it Buy.
- Strongest
- ValuationA+
- Weakest
- ProfitabilityD
All factor grades
- ValuationA+
- Financial StrengthA-
- GrowthB+
- MomentumB
- ProfitabilityD
- Piotroski3/9
Contact
BNR stock: frequently asked questions
What is BNR's ST Score?
Burning Rock Biotech Limited (BNR) has an ST Score of 59.3 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is BNR a buy, hold, or sell?
Analysts rate BNR a Buy. Our ST Score grades it B- (59.3/100). The ST Score is a data-driven signal, not a recommendation.
What are BNR's factor grades?
Valuation A+, Profitability D, Financial Strength A-, Momentum B, Growth B+.
What is BNR's valuation grade?
Burning Rock Biotech Limited (BNR) earns a valuation grade of A+, measured against Medical - Diagnostics & Research peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is BNR's growth grade?
Burning Rock Biotech Limited (BNR) earns a growth grade of B+, measured against Medical - Diagnostics & Research peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is BNR's profitability grade?
Burning Rock Biotech Limited (BNR) earns a profitability grade of D, measured against Medical - Diagnostics & Research peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is BNR's financial strength grade?
Burning Rock Biotech Limited (BNR) earns a financial strength grade of A-, measured against Medical - Diagnostics & Research peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is BNR's Piotroski score?
Burning Rock Biotech Limited (BNR) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.